A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.
- Conditions
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 101
- Registration Number
- NCT06024213
- Locations
- 🇫🇷
Hôpital Européen Georges-Pompidou Paris, Paris, Île-de-France, France
🇫🇷Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
🇫🇷CHU de Saint-Etienne, Saint-Etienne, Loire, France
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
- Conditions
- Interventions
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT01864200
- Locations
- 🇺🇸
Georgia Regents University, Augusta, Georgia, United States
🇺🇸St Joseph Regional Health Center, Bryan, Texas, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
Copperhead Envenomation Observational Study
- Conditions
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01651299
- Locations
- 🇺🇸
Duke Medical Center, Durham, North Carolina, United States
🇺🇸Washington University, St. Louis, Missouri, United States
🇺🇸Vidant Health, Greenville, North Carolina, United States
Open-label Safety and Tolerability Study of CoVaccine HTâ„¢ in Healthy Volunteers
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2014-09-15
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01015703
- Locations
- 🇬🇧
Quintiles Drug Research Unit, London, United Kingdom
Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation
- Conditions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 247
- Registration Number
- NCT00927381
- Locations
- 🇺🇸
Rocky Mountain Poison and Drug Center, Denver, Colorado, United States
Study of Anti-tumour Effects and Safety of Prolarixâ„¢ in Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT00746590
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00702221
- Locations
- 🇬🇧
Saltash Health Centre, Saltash, Cornwall, United Kingdom
🇬🇧Cape Cornwall Surgery, St. Just, Cornwall, United Kingdom
🇬🇧Abbey Meads Medical Practice, Swindon, Wiltshire, United Kingdom
Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
- Conditions
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00634504
- Locations
- 🇺🇸
Oakland's Children's Hospital, Oakland, California, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2014-09-15
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT00634322
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
- Conditions
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- BTG International Inc.
- Registration Number
- NCT00481559